TransMedics

TMDX

TransMedics (TMDX)

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in...

Open
--
High
--
Low
--
Prev. Close
--
Volume
--
Turnover
--
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
--
Volume Ratio
--
Turnover Ratio
--
52wk Low
--
Float Mkt Cap
--
Market Cap
--
P/ETTM
--
P/EDynamic
--
P/EStatic
--
EPSTTM
--
EPSDynamic
--
EPSStatic
--
BVPS
--
P/B
--
Circulating Supply
--
Dividend YieldTTM
--
DividendTTM
--
Shares
--
Min lot size
--
Currency
--

TransMedics Analyst Rating

View more

Forecast & Rating

Oct 27, 2026
Price forecast
$98.7349.61%
Forecast & RatingBuy
13analysts
  • Strong buy46.15%
  • Buy23.08%
  • Hold30.77%
  • Sell0.00%
  • Strong sell0.00%

News

Bullish vs. Bearish — Last 3 Months

2.9k followers · 0 opinions
▲Bullish50%
50%Bearish▼
  • H
    Hardik Shah

    $TransMedics(TMDX.US) | Needham 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗕𝘂𝘆 on 𝗧𝗿𝗮𝗻𝘀𝗠𝗲𝗱𝗶𝗰𝘀 𝗚𝗿𝗼𝘂𝗽, PT $𝟭𝟬𝟲

    Analyst sees Araujo’s finance and international experience as well suited to TransMedics’ increasingly complex global business.

    图片 1,共 1 张
  • H
    Hardik Shah

    🚨 After-market buzz!

    $Digital Turbine(APPS.US) $Upstart(UPST.US) $Arista Networks(ANET.US) $Wynn Resorts(WYNN.US) $TransMedics(TMDX.US) $Booking(BKNG.US) $Coupang(CPNG.US) $Opendoor Tech(OPEN.US) $DaVita(DVA.US) $SpaceX(SPCX.US) $Bed Bath & Beyond, Inc.(BBBY.US) $AMD(AMD.US) $Zeta Global(ZETA.US) $Pinterest(PINS.US) $Lucid(LCID.US) $Match(MTCH.US) $Teradata(TDC.US)

    图片 1,共 1 张
  • H
    Hardik Shah

    $TransMedics(TMDX.US) | Stifel reiterates 𝐇𝐨𝐥𝐝 on 𝐓𝐫𝐚𝐧𝐬𝐌𝐞𝐝𝐢𝐜𝐬, maintains 𝐏𝐓 𝐚𝐭 $𝟖𝟎

    Analyst sees near-term caution, flagging that a Q2 revenue beat is less likely due to 'dry-runs' and that 2026/27 EPS estimates may need a reset.

    图片 1,共 1 张